Christian Angermayer and Apeiron Investment Group Ltd. Buys $298K of Atai Life Sciences N V (ATAI) — SEC Form 4, Apr 26, 2022

Open-Market Net Purchase · SEC Form 4
+$297,805

Equity position changed by +3.8%

Reporting Owners
TXN 2022-04-25 · FILED 2022-04-26
Equity Position 1.68M sh 1,614,911 → 1,676,692
Equity Change +3.8% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2022-04-26
Report Date
2022-04-22
Accession No.
0000899243-22-015653
Accepted At
2022-04-26 20:15 UTC
Reporting Owners
Name Relationship
Christian Angermayer CIK 0001845872
10% Owner
Apeiron Investment Group Ltd. CIK 0001845711
10% Owner
Christian Angermayer at Atai Life Sciences N V Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Atai Life Sciences N V
2025-10-02 - — View
2025-08-18 Buy +$18,999,999 View
2025-06-27 Award — View
2025-06-04 Award — View
2025-03-24 Buy +$2,520,000 View
All filings by this insider at Atai Life Sciences N V
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common SharesF1 2022-04-22 P - Purchase 52,820 A $4.83 +$254,962 1,667,731 Indirect
Common SharesF2 2022-04-25 P - Purchase 8,961 A $4.78 +$42,843 1,676,692 Indirect
Footnotes (2)
F1
The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.77 to $4.90 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Show more
F2
The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.72 to $4.80 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Show more
5%+ Holders · 13D/G 1 filer
Other insiders at Atai Life Sciences N V
All Atai Life Sciences N V insider activity
GET /v1/forms/4/0000899243-22-015653 API docs
View Original SEC Filing